SCLX: Product Gets FDA Approval and Hits Market
SCLX is filling a much-needed area of the health care sector, that of developing non-opioid pain relief products. The company already has...
307 Views
SCLX: Making Decisions That Should Boost Revenue
SCLX is filling a much-needed area of the health care sector, that of developing non-opioid pain relief products. The company already has...
246 Views
SCLX: Making Decisions That Should Boost Revenue
SCLX is filling a much-needed area of the health care sector, that of developing non-opioid pain relief products. The company already has...
249 Views
SPAC Talk: Upcoming Lock-Up Expirations May Need a Health Warning
KEY HIGHLIGHTS SPAC IPO activity is nothing to write home about, but it’s outpacing traditional IPOs. The SPAC IPO market continues to trundle...
747 Views
The SPAC Week in Review
Vickers Vantage Corp. I (VCKA) & Scilex Holding Company (a subsidiary of Sorrento Therapeutics)Â (Valuation: $440M EV). Pono Capital Corp (PONO) &...
398 Views